Current strategies for treatment of intervertebral disc degeneration: substitution and regeneration possibilities by van Uden, Sebastião et al.
REVIEW Open Access
Current strategies for treatment of
intervertebral disc degeneration:
substitution and regeneration possibilities
Sebastião van Uden1,2,4,5* , Joana Silva-Correia1,2, Joaquim Miguel Oliveira1,2,3 and Rui Luís Reis1,2,3
Abstract
Background: Intervertebral disc degeneration has an annual worldwide socioeconomic impact masked as low back
pain of over 70 billion euros. This disease has a high prevalence over the working age class, which raises
the socioeconomic impact over the years. Acute physical trauma or prolonged intervertebral disc mistreatment triggers a
biochemical negative tendency of catabolic-anabolic balance that progress to a chronic degeneration disease. Current
biomedical treatments are not only ineffective in the long-run, but can also cause degeneration to spread to
adjacent intervertebral discs. Regenerative strategies are desperately needed in the clinics, such as: minimal invasive
nucleus pulposus or annulus fibrosus treatments, total disc replacement, and cartilaginous endplates decalcification.
Main body: Herein, it is reviewed the state-of-the-art of intervertebral disc regeneration strategies from the perspective
of cells, scaffolds, or constructs, including both popular and unique tissue engineering approaches. The premises
for cell type and origin selection or even absence of cells is being explored. Choice of several raw materials and
scaffold fabrication methods are evaluated. Extensive studies have been developed for fully regeneration of the
annulus fibrosus and nucleus pulposus, together or separately, with a long set of different rationales already reported.
Recent works show promising biomaterials and processing methods applied to intervertebral disc substitutive
or regenerative strategies. Facing the abundance of studies presented in the literature aiming intervertebral
disc regeneration it is interesting to observe how cartilaginous endplates have been extensively neglected,
being this a major source of nutrients and water supply for the whole disc.
Conclusion: Several innovative avenues for tackling intervertebral disc degeneration are being reported – from acellular
to cellular approaches, but the cartilaginous endplates regeneration strategies remain unaddressed. Interestingly, patient-
specific approaches show great promise in respecting patient anatomy and thus allow quicker translation to the clinics in
the near future.
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Background
The intervertebral disc (IVD) can be subjected to a great
range of changes throughout a person’s life [1]. An
underlying IVD degeneration (IDD) might be developing
alongside with these age-related changes. IDD can be
triggered by a single event of acute overloading, such as
the lifting of a heavy object. It could alternatively be
derived from a long-term repetitive IVD mistreatment
without providing the proper conditions and time for
the tissue to recover. With aging, this disease can be
induced with a single event of acute over-loading of
progressively less intensity. IDD may progress to serious
condition due to important physiological changes that
can include: Water loss, healthy extracellular matrix
(ECM) synthesis decrease and phenotype change, in-
creased cell senescence, and several other modifications
at the biomolecular level [2, 3]. Ultimately, such bio-
logical transformations can lead to severe morphological
changes, expressed in the form of pathologies.
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The biomechanical functioning of IVD relies on a balance
between the three main tissues that compose it: Two cartil-
aginous endplates – hyaline-like tissue located at the edge
of the neighbour vertebras, the nucleus pulposus (NP) –
gelatinous tissue at the centre of the IVD, and the outer
and inner annulus fibrosus (AF) – two partially concentric
strong elastic-like tissues surrounding the whole IVD [4].
The latter two, although slightly different from each other,
will be regarded in this review as one AF when its division
is not required, for simplicity purposes.
The AF, as a whole, behaves like a strong elastic
material. This, however, could be a reductionist view of
this tissue, since this behaviour could be derived from a
low concentration of strategically located elastic fibres
that convey recoil properties to the collagen fibre bundles,
returning these to their pre-stressed dimensions when
relaxed. Biomechanics is strongly influenced by the NP’s
water concentration. Water presence is, by its turn,
directly related with the biochemical composition of the
tissue. In this respect, proteoglycans (PG’s) specifically
play a major role in this water-biochemistry relation, due
to their extremely hydrophilic nature. PG’s are responsible
for the presence of up to 80% water concentration within
a young and healthy NP [5]. When the IVD is compressed,
the water molecules are released from the PG’s, following
the lines of mechanical tension that progress from the
cartilaginous endplates through the NP until the outer
edges of the AF. After the loading cycle is finished water is
again attracted towards the PG’s at the centre of the IVD,
through diffusion derived from the closest blood vessels.
In healthy IVDs, this near vascularisation is located at the
cartilaginous endplates, which provide hydration as well
as nutrition to the whole IVD [6]. With aging, the cartil-
aginous endplates progressively lose permeability due to
calcification, cutting this essential water supply. However,
due to the complexity of the pathways of water, nutrients,
waste and oxygen within the whole IVD, the literature is
not absolutely conclusive [7]. It seems that along the pro-
gressive shutdown of the endplates’ pathway, the water
concentration gradually decreases within the IVD. This
might force the water to return to the NP through the
AF influencing a non-healthy region homeostasis with
debilitated water, nutrient and waste renewability. It is
clear, nevertheless, that it leads to: NP ECM remodel-
ling unbalance, IVD loss of hydration, as well as height
decrease, and abnormal force distribution. Ultimately,
all these changes are responsible for the appearance of
IDD morphological signs [8].
The fundamentals related to the biological and molecu-
lar changes derived from an IVD under degeneration are
described. The set of prospective and recent studies
that have been reported, ranging from biomaterials-
based to cellular approaches, are also herein over-
viewed (Fig. 1).
Intervertebral disc degeneration (IDD): biological and
molecular changes
Biological and molecular changes underlie the morpho-
logical signs of IDD. Several cellular changes occur during
IDD, namely in: Type, concentration, death, proliferation,
senescence, and phenotype. All these changes have a non-
healthy impact on the biochemical synthesis and its conse-
quent composition, which leads to an unbalanced ECM
remodelling, and ultimately to hydration loss [9].
The IVD is composed of different types of cells and
cell type concentrations in its different tissues. The cartil-
aginous endplates, in resemblance to the hyaline cartilage,
are composed of chondrocytes. The elongated fibroblast-
like cells can be found in the outer part of the AF, while the
inner part of the AF has more rounded chondrocyte-like
cells. The cell population in these tissues does not change
significantly with aging. However, it can greatly vary within
the NP [1]. The cartilaginous endplates and the whole AF,
as most of the spinal structures, are derived from the meso-
derm germ layer, but not the NP [10]. The NP originates in
the endoderm germ layer, which is also the notochordal
cell’s origin. It is believed, that the young NP tissue does
not have the chondrocyte-like cells, but only notochordal
cells, that disappear by the end of the first decade of life
[11]. The notochordal cells are gradually replaced by chon-
drocyte-like cells, which are believed to migrate from the
inner AF, from the cartilaginous endplates, or both [12].
There is, however, some controversy around the cell con-
centration changes within the NP. Zhao et al. [1] reported
that cell concentration has its turnovers in parallel with the
change of cell type predominance. As notochordal cells
start to decrease, the cellular concentration significantly
declines creating a positive feedback for chondrocyte-like
cells to migrate and proliferate into the NP. These cells gain
concentration along with IDD progression. Bae et al. [13],
however, claims that the degenerated IVD cellular concen-
tration is lower than in healthy IVDs due to gradual loss of
optimal cellular environment conditions. Both hypotheses
present strong arguments, possibly indicating a wide vari-
ability of possible IVD aging and degeneration progressions
in humans.
Cellular environment progressively changes due to
scarcity of nutrition and waste removal pathways as
cartilaginous endplates calcify, causing initial cell death
(Fig. 2) [14]. With IDD progression, ingrowth of blood
vessels accompanied by nerve growth occurs into the AF
continuing into the NP, in a later stage [15]. This tends
to increase nutritional accessibility and waste removal
rates, which by its turn can provide conditions to in-
crease cellular concentration within the NP. With this
neo-vascularisation proximity, however, also the oxygen
concentration rises, leading to overall biochemical envir-
onment towards a normoxic NP environment that di-
verges from a healthy IVD [16]. NP cells’ phenotype and
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activity is stimulated by hypoxia. Ultimately, a prolonged
excessive availability of oxygen leads these cells to a
senescent state, which negatively impacts long term
cellular concentration [17, 18].
A healthy AF is largely composed of collagen type I
whereas the NP is mainly composed of collagen type II
and aggrecan [1]. Other molecules are also present in the
NP at low concentration, namely: Fibronectin, collagen
type I, III, V, VI, IX and XI, and other types of PG’s, such
as: Biglycans, decorin and fibromodulin [9]. In healthy
IVD, there is also a production of catabolic molecules with
increased expression while degeneration develops. These
molecules are matrix metalloproteinases and aggreca-
nases, responsible for breaking down the ECM to allow
its natural remodelling cycle. Matrix metalloprotainases-1,
2, 3, 7, 8 and 13 are expressed in the NP. In addition, there
is also an increased cytokine production, such as: Tumour
necrosis factor-α, interleukin-1α and -1β. These molecules
Fig. 1 Image bundle of current state-of-the-art research strategies to treat IDD, described in this review, such as (1) injectable NP hydrogel, (2)
minimal invasive scaffold for AF scaffold, (3) full AF scaffold, and (4) biphasic scaffold for total IVD replacement. Permissions: 1 – images used in
this scheme were adapted from two articles of Silva-Correia et al. [62, 81]; 2 – images used in this scheme were adapted from Xin et al. [93] under
the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/); 3 – images used in this scheme were
adapted from van Uden et al. [99] © IOP Publishing. Reproduced with permission. All rights reserved; 4 – images used in this scheme were
adapted from Choy et al. [95] under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)
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also promote matrix metalloproteinases’ synthesis, which in
degenerated IVDs can reach levels that have a devastating
effect over the ECM [19]. Zhao et al. have summarized the
biochemical changes caused by IDD, which complements
this brief description of matrix remodelling mediation [1].
The phenotype change undergone by NP cells is pos-
sibly the highest responsible factor, within the NP, for the
morphological transformations derived from IDD. This
shift in cell expression influences directly the hydrophilic
anabolic-catabolic ECM balance. Overall, IVD hydration
decreases while more matrix is degraded than it is pro-
duced, ultimately leading to IVD hardening and unhealthy
biomechanical behaviour [18].
NP hydraulic permeability greatly depends on the
magnitude of compression force requested by the IVD.
Heneghan et al. [20] defined a mathematical formula
explaining this phenomenon, which is given by equation 1.
k λð Þ ¼ 1:59 10−15 λ−0:2
0:8
 1:13
e
−
0:02 λ2−1ð Þ
2
h i
ð1Þ
The function of IVD permeability is given by k in rela-
tion to the stretch ratio λ, corresponding to the ratio
between the compressed sample’s height (h) and the ori-
ginal uncompressed height (h0). On the apparatus used
by this research group, a human IVD is submitted to a
certain compression strain, while the inlet and outlet
flows are measured. This experiment describes an expo-
nential relation between permeability and compression
(0 ≤ λ ≤ 1). Interestingly, until a certain magnitude of
Fig. 2 Cascade of events associated with IDD morphological signs. Starting by a contribution of an acute or a repeated set of acute loading
forces that, as tissue aging progresses, becomes lighter to set IDD. The highlighted areas divide the events by tissue/groups of tissue – Red: IVD;
Green: NP; Blue: AF and cartilaginous endplates. NP: nucleus pulposus; AF: annulus fibrosus; IVD: intervertebral disc; CEP: cartilaginous endplates;
IDD: IVD degeneration disease
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compression (λ ≤ 0.2) the tissue is not permeable, pos-
sibly implying the need for IVD loading cycles to create
an optimal micro-environment [20]. However, this for-
mula can only be applied when the NP is healthy, when
the degeneration starts the PG number decreases and
the permeability increases together with it, i.e. the water
retention decreases and the whole IVD decreases its
biomechanical performance. A regular loading becomes
an overloading, which also becomes a factor to progress
further on the degeneration state that will in the end
reduce even more the mechanical capacity, and the cycle
continuous following a recessive spiral [21, 22].
Prospective strategies for intervertebral disc (IVD)
regeneration
In accordance with the severity of the IDD, different treat-
ment strategies can be applied. These can be invasive or
not, and pharmacological or not. A Swedish massage or
acupuncture, for example, is a non-pharmacological and
non-invasive treatment commonly used for managing low
back pain, a symptom that is strongly related with IDD
[23]. Pharmacological treatments are also used for acute
strong pain expressivity, such as lumbar muscle spasm
commonly managed with muscle relaxant. However, non-
invasive treatments have a limit and do not help resolving
more severe conditions, in which repair strategies such as
spinal fusion or screws implantation must be applied.
These, are very effective in eliminating the pain, but re-
duce spine flexibility [24]. Additionally, due to the mech-
anical properties’ discrepancy between the implants and
the biological tissues, local trauma can produce dramatic
repercussions. If that is not the case, long term presence
of these devices in the spine alters progressively the bio-
logical properties of adjacent tissues, possibly inducing de-
generation of neighbour IVDs [24].
Advanced regenerative strategies, currently under re-
search, aim for total IVD regeneration by addressing all
previous signs of degeneration, maintaining the treated
IVD in homeostasis with its environment. Tissue engin-
eering is a clinically innovative driving force focused on
this objective.
The gold standard diagnostic tool for IDD is magnetic
resonance imaging (MRI). The degeneration-associated
morphological changes observed, using the equipment,
are more evident on the NP than for the AF or the car-
tilaginous endplates [25, 26]. Possibly, for this reason,
the tissue engineering’s initial IVD research efforts were
carried out to address the huge challenge of NP regener-
ation (Fig. 3). Cell-loaded hydrogel injection solutions
were initially envisioned to regenerate the NP, believing
this could be the pivot for a total IVD regeneration.
Some cases can benefit from this minimally invasive
intervention, mostly light to medium severity IDD con-
ditions. In advanced states, however, the AF has lost its
mechanical integrity to support a full NP’s volume and
its highly hydrated consistency, creating a tendency for
herniation [27]. Research strategies for the combined
regeneration of the AF and NP started to become more
common. However, results were not as effective as pos-
sibly predicted. It is conceivable that ignoring the essen-
tial role of the cartilaginous endplates is the missing
piece for a successful regeneration strategy.
The tissues that compose the IVD are closely related,
working symbiotically to maintain the whole IVD healthy
and functional. If one tissue is left degenerated, the ap-
plied regenerative strategy, although demonstrating short
to medium term positive results, will probably fail in the
long run. The cartilaginous endplate nutrition and waste
removal pathway needs to be re-established for a complete
IVD healthy homeostasis. Nonetheless, without a vigorous
NP hydrophilic matrix, water retention remains scarce,
and this pathway remains blocked or minimized, and the
hidden tissue regeneration potential is not stimulated as a
whole – the NP needs to be addressed as well. Yet again,
if the AF does not have the capability to withhold the NP,
the material used for regenerating the NP will herniate
outside the IVD, possibly causing low back pain. With this
rationale, we return to the beginning of the regeneration
strategies’ loop, indicating that every degenerated IVD tis-
sue should be treated for the whole strategy to succeed.
Extensive innovative efforts for NP and AF regeneration
have been investigated, and the most important examples
are herein discussed. Cartilaginous endplates’ targeted re-
generation seems to be the missing link that will enable
their full success.
Fig. 3 Scheme of a tissue engineering strategy applied to the IVD
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Nucleus pulposus (NP)
When aiming to regenerate the NP, the water content
must be addressed if the biochemical environment has
been compromised. Hydrophilic materials, such as hydro-
gels are used to substitute the water uptake responsibility,
while newly implanted cells have time to produce native
PG-based ECM. If, however, the native matrix is still
mildly rich in hydrophilic molecules a cell-based
strategy alone, carried by a non-polymerizable carrier
might be enough.
Cell-based strategies aimed to regenerate the IVD con-
cern strictly on increasing the NP cell concentration to
renew biochemical environment by synthesis of ECM.
This is addressed by cell injection not only to increase
cell number but, more importantly, to boost the active
cellular population [28, 29]. Since, as aforementioned,
the matrix is gradually lost due to the native cells’
change in behaviour, which seize to produce PG’s at an
even rate as the remodelling proteins catalyse the ECM
[13]. The cells of a NP with advanced state of degener-
ation are senescent and need to be replaced with resili-
ent and vigorous ECM producers.
Cells for nucleus pulposus (NP) regeneration
Cell therapy approaches for IVD regeneration are based
on injecting NP-like cells, responsible for synthesizing
PG’s when in situ. Therefore, the first decision factor is -
what is the right type of cells to be used? If native NP
cells (Fig. 4) need to be replaced they surely cannot be
used, due to their senescence or diseased phenotype ex-
pression [30, 31]. Fortunately, it is possible for this to be
a wrong argument in the near future, since Abbott et al.
[32] have been working on increasing senescent human
NP cells metabolic activity, proliferation, glycosaminogly-
can production, and stimulate non-degenerated pheno-
type. They believe that native cells from a NP in a severe
state of degeneration have, in fact, a regenerative potential
that can be explored. Exposing this type of cells to a cock-
tail of specific growth factors, to notochordal cells’ condi-
tioned medium, or both, constitutes a promising strategy
to enhance glycosaminoglycan production phenotype as a
means for an effective treatment. In their study, they
retrieved cells from a human source. After expansion,
under the three aforementioned conditions, cells were
implanted in rabbit models with induced IDD (induced by
needle-punctures). Results demonstrated not only that
cells stayed viable for up to 24 weeks, but also that this
strategy delayed the degeneration progression [32]. A spe-
cific follow-up of this work would be very interesting to
increase scientific information on the strategy’s potential.
Nonetheless, work being developed by these authors has
been very revelling, i.e. by Iatridis, Purmessur and co-
workers, such as the work on the effect of notochordal
conditioned media and its derived factors in inhibiting
vessel and nerve growth [33, 34].
The use of notochordal cells to be implanted in degener-
ated IVDs is also being considered as a cell-based strategy,
whether from stem cell-derived allogeneic or even xeno-
geneic origin, or from autologous origin, based on specific
differentiation protocols. However, as Arkesteijn et al. ob-
served [35], there was no change in anabolic response
within the ex vivo NP culture when the xenogeneic noto-
chordal cells were implanted (porcine cells in bovine NP).
Additionally, seeded notochordal cells did not display a
native morphology by the end of the culture period – 42
days. A different conclusion from the observations reported
by other studies [36, 37], possibly due to a non-realistic
clinical approach regarding a very high number of noto-
chordal cells used in the other studies, they say. A discrep-
ancy in ratio of notochordal cells in relation to native NP
cells of 20:80 instead of 50:50 might be the reason for the
lack of success [35]. Possibly unrealistic clinical approaches,
although good at extending scientific knowledge, might not
be able to be directly used as a patient treatment, but can
certainly provide a basis for other strategies that will.
Properties of notochordal cells’ conditioned medium
have also been in the line of research of Bach et al. [38],
whose research led to the conclusion that notochordal
cells condition medium derived from human, canine and
porcine, had a regenerative effect on human chondro-
cyte-like cells (herein named as NP cells for simplicity
purposes). Meaning that human notochordal condition
medium is not required to achieve that effect, since ca-
nine or porcine have an approximate effect [38]. Porcine
notochordal cells conditioned medium can, therefore, be
used for different treatment strategy purposes, due to its
potential for extensive availability. Autologous senescent
NP cells could be isolated and cultured with this condi-
tioned medium and be delivered back to the diseased
IVD. Differentiated autologous stem cells could be
Fig. 4 Micrograph of human NP cells after 3 days in culture. Scale
bar: 50 μm
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cultured in this medium to boost their maximum hydro-
philic matrix synthesis potential before implantation.
The prospect of using stem cells in cell-based strategies
for IVD regeneration brings with it the concern of how to
guide differentiation into fully functional NP cells. Stem
cell research efforts (e.g. induced pluripotent stem cells)
[39] have been helping to reduce the obstacle of stem cell
number availability. Concerning specifically the differenti-
ation of stem cells into NP cells, the initial number of cells
required significantly depends on the method that is being
followed. It is feasible, in principle, either in vitro or in situ.
The in vitro differentiation method has the advantage
of assuring that the implanted cells have the optimal
phenotype, though, with the disadvantage of more stem
cells being required. Additionally, stem cell expansion is
not trivial, and many cells are lost while differentiating
into NP cells [40]. The key factor, in IVD regeneration is
hypoxia (2% O2), since this is the environment that NP
cells are acquainted. In vivo, these cells can be up to 2–3
mm away from the closest blood vessel [17, 18]. There-
fore, the most promising strategy to ensure that stem
cells differentiate into metabolically active NP cells
might be to culture them in a hypoxic environment.
However, a lot of stem cells tend to die due to the lack
of oxygen, requiring even more stem cells at start.
Fang and his co-workers [40] have been studying the
hypothesis of manipulating mesenchymal stem cells in
order to make them resistant to hypoxia by adding an
anti-apoptotic gene called B-cell lymphoma-2. By avoid-
ing stem cells to suffer apoptosis at the early stage of
differentiation, pre-chondrocyte-like phenotype cells were
produced to be resistant to low concentrations of oxygen,
thus being able to maintain cell numbers under this con-
dition. Half of the number of stem cells needed was used.
Nevertheless, a serious doubt remains – does this not in-
crease the chance of cancer cell formation? Manipulating
directly stem cells by decreasing their ability to resort to
apoptosis is a step towards cells being unable to commit
apoptosis, and losing the ability to die, which would make
them virtually cancer cells. Nevertheless, this work brings
great promise and, if proven safe, there is no reason why
this method cannot be applied as a treatment strategy for
IVD regeneration.
In situ differentiation method has the advantage of
using a standard approach for stem cell expansion.
Leckie and co-workers [28] developed a work following
this type of cell-based method. Its purpose was to deter-
mine whether injecting human umbilical tissue-derived
cells into the NP would improve the course of IDD. The
cells were injected with phosphate buffer solution, EVI-
CEL®-based carrier alone and cell-laden EVICEL®-based
carrier. Briefly, EVICEL® is a combination of a fibrinogen-
based solution with a thrombin-based solution, both de-
rived from human plasma. Follow-up was based on MRI,
biomechanics and histologic findings. The results were
significantly away from the positive control (non-punc-
tured IVDs), and failed to fully restore MRI signs for non-
degenerated IVDs, possibly due to the unclear choice of
carrier. A different hydrogel might have produced signifi-
cantly more interesting results. However, they were suc-
cessful in slowing down the degeneration process and
showed better results than the negative control (punc-
tured IVDs). At 12 weeks, the MRI results showed that
cells alone and cells delivered using EVICEL®-based car-
riers were significantly distinct from punctured values. Re-
garding the viscoelastic properties, the cell-free carrier
and cells in EVICEL®-based carrier were significantly
closer to positive control (non-punctured IVDs) than the
cells alone. However, if the biological and biochemical
conditions within this tissue are not modelled, the use of
this method could stimulate the growth of blood vessels
and nerve endings inside the NP. In the literature, there
are evidences that the appearance of blood vessels and
nerve endings inside the NP might be originated by native
stem cells [41]. Therefore, the injection of more stem cells
without a modulated differentiation pathway in a diseased
environment could promote this, as well as deteriorate the
state of the tissue by further degenerating it.
Processing of scaffolds for the nucleus pulposus (NP)
When the NP biochemical environment has no conditions
to maintain a healthy cellular activity, a highly hydrophilic
material should be implanted. This material, typically a
hydrogel, is meant to create suitable conditions for cells to
express healthy chondrocyte-like phenotype. With time,
native hydrophilic ECM is produced while the hydrogel
degrades, ideally, at an even rate. Therefore, when choos-
ing the right biomaterial to mimic a healthy NP cellular
environment, several properties must be considered, as
described in Table 1 [5, 42–46].
Considering all the properties in Table 1, hydrogels
stand out as an ideal candidate material (Fig. 5). Hydro-
gels are polymeric networks with the capacity to absorb
water from 10 up to 100 times its dry weight. [47]. Sev-
eral kinds of hydrogels, natural and synthetic, have been
studied for IVD tissue engineering strategies [48].
There is a growing interest in natural-origin hydrogels
that are able to be processed but not synthesised, which
significantly reduces production costs. Other reasons for
why they are becoming more attractive might be their
low level of cytotoxicity, their wide range of possible
tissue engineering applications, as well as astonishing
biological properties, such as: Bioactivity and bioactive
degradation, while available for cellular remodelling and
cell adherence [49–51].
Although hydrogels from natural-origin offer a wide
range of biological advantages, it might be difficult to find
van Uden et al. Biomaterials Research  (2017) 21:22 Page 7 of 19
the desired range of physical properties. Nonetheless, know-
how on these materials is widening, new materials are being
studied and new processes are being developed to tune the
right properties [47, 52]. The IVD has a slow metabolism,
which leads to long regeneration time. The degradation rate
of the hydrogel to be implanted needs to match this time
frame [53]. Some natural-origin hydrogels have been pro-
posed in the literature. The hydrogels that seem to be more
popular for NP regeneration are based on the following raw
materials: Alginate [54–56], chitosan [48, 51, 57, 58], colla-
gen [51, 59, 60], gellan gum [48, 49, 61–65], and hyaluronic
acid [48, 51, 57, 66] (Table 2 [48, 49, 51, 54–60, 66, 67]).
In alternative, synthetic hydrogels provide predictable
and reproducible chemical and physical properties that
might be tuned for different tissue engineering applica-
tions, e.g. degradation rate according to the aimed tis-
sue regeneration rate. Moreover, they easily blend with
polymers that broaden even more the properties possibil-
ities [68]. Since they are made of well-known molecules,
when pure, they have a low risk of immunogenicity,
infection and toxicity [51, 69]. Though, they lack bioactiv-
ity that is characteristic of natural-origin materials, and
their manufacturing process is, in general, economically
less attractive, which are two key disabling factors for a
tissue engineering application. Hence, while natural-origin
materials lack diversity of properties, synthetic materials
lack options that are economically viable. Some examples
of synthetic hydrogels being applied in NP tissue engineer-
ing strategies are: Polyethylene glycol [27, 70], polyvinyl
alcohol [71, 72] and polyvinylpyrrolidone [51, 73, 74]
(Table 2). There are, indeed, not many studies using
just synthetic-based materials for NP regeneration. The
interesting possibility, however, is to use a natural-
based material modified with synthetic polymers to
achieve the advantages of both types [56, 60].
Combined therapy: cell-seeded scaffolds for nucleus pulposus
(NP) regeneration
A self-assembling peptide called RADA16-I [Ac-(RADA)4-
CONH2], with the ability to form hydrogels, was proposed
by Tao et al. [75] as cell carrier for NP tissue engineering.
Interesting predisposition of this material to form β-sheet
configurations when within water was reported. Due to its
C-terminus, it is possible to conjugate this peptide with
various bioactive short-peptide motifs. The conjugation
of three different short peptides of bone morphogenetic
proteins-7 was evaluated [75], and a 1:1 ratio of RADA-
KPSS [AC-(RADA)4-GG-KPSSAPTQLN-CONH2] with
RADA16-I, named RADA-KPS, was found as the optimal
functional formulation to promote proliferation and acti-
vate, in vitro, degenerated NP cells to express collagen II
and aggrecan. Wu et al. [76] further demonstrated that
bone marrow mesenchymal stem cells, encapsulated
within RADA-KPS, had a time-related increase in ex-
pression of factors typical of metabolically active NP
cells – collagen II and aggrecan.
The idea of using collagen II hydrogels for NP regen-
eration is natural, since it is one of its most prevalent
ECM components, when healthy [1]. Although this
Table 1 Overview on the NP treatment approach from the materials engineering perspective
Problem Solution References
1 Accessing the NP is only possible through the AF, leaving
fissures that increase probability of herniation appearance.
Injectable material – so that only the area of the needle’s section of the
AF is wounded.
[42]
2 The material cannot be polymerised before implantation,
if it needs to be injected.
Material able to polymerize in vivo, by pH, ion interaction, temperature,
light, or another possible factor.
[43, 44]
3 The NP tissue of a degenerated IVD tends to be a hostile
environment for cells.
The material’s mechanical properties should be as close as possible with
the mechanical properties of a healthy NP tissue. Hence, re-establishing
IVD height and biomechanical function.
[45]
4 Cells injected in the NP of degenerated IVDs tend to lose
the desired phenotype, due to the lack of hydrophilic
molecules.
The material must be able to absorb a lot of water, at least 80%, just as
a healthy NP matrix.
[5]
5 Non-degradable materials do not create or limit the
space for new healthy tissue to grow.
The degradability rate must match the tissue’s rate of regeneration, not
being at the expense of the mechanical properties.
[46]
Fig. 5 Methacrylated gellan gum discs with a diameter of 10 mm
and a height of 5 mm. Scale bar: 10 mm
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material has a very high cost, its advantages might com-
pensate for that matter. Tao et al. [59] demonstrated that
collagen II hydrogel formulations with higher concentra-
tion increase the tendency of initially seeded adipose
derived stem cells to express a NP cell-like phenotype.
However, collagen II on its own does not seem to pos-
sess the required mechanical properties for NP tissue
engineering, a cross-linker or a material to blend seems
to be required [77]. From the same research group,
Zhou et al. [60] used N,N-(3-dimethylaminopropyl)-N’-
ethyl carbodiimide together with N-hydroxysuccinimide,
which according to their literature search are non-cytotoxic.
In their study, it was evaluated the proliferation and differ-
entiation effect of this cross-link formula on collagen II
hydrogels with encapsulated adipose derived stem cells. Cell
proliferation almost doubled from 7 to 14 days of cultures,
such as the control – same cell type on tissue culture
polystyrene substrate, demonstrating no cytocompat-
ibility change due to cross-linking. The substantial
positive evidence lays on the gene expression profiles,
since the control seems to show no significant differ-
ence on the typical NP cells’ phenotype profile between
7 and 14 days of culture. While for the cross-linked
collagen II hydrogels, all gene expressions analysed
increased about 20-50% over the non-cross-linked on
both time-points, with a slight drop difference on the
collagen I expression – a non-typical ECM molecule of
healthy NP. Continuing comparing these results with
the non-cross-linked collagen II hydrogels, the gene
profile expression was more interesting but the increase
in rate of expression was practically the same. Demon-
strating that it is possible to maintain a good differenti-
ation profile, while achieving higher mechanical properties
with this cross-link formula.
Gellan gum material (Fig. 6) was first proposed by Oli-
veira et al. [78–80] for cartilage tissue regeneration. Cyto-
compatibility towards chondrocytes was demonstrated as
well as the ability to polymerize with both temperature
and pH change. Silva-Correia et al. [47], however, first spe-
cifically proposed its application for NP regeneration. In
several studies the gellan gum’s properties were exten-
sively characterized, such as: Rheology [63], biocompati-
bility [81], and non-angiogenic potential [62]. Pereira et al.
[82] proposed the use of gellan gum microparticles within
a gellan gum matrix with different ratios of high- or low-
acyl gellan gum. An interesting rationale considering the
cellular capsules’ configuration typically observed in native
NP [83]. Moreover, the independent reactions of glycidyl
methacrylate and methyl benzoylformate, reported by
this research group, demonstrated the versatility of this
material to be tuned to acquire stronger mechanical
properties and ultra-violet light polymerization [84]. In
contrast with methacrylation reaction, an alternative to
increase gellan gum’s mechanical properties was
developed by Thorvaldsson et al., who proposed an in-
teresting rationale to develop hydrogels of that same
material reinforced with electrospun polycaprolactone
(PCL) nanofibers. Therefore, mimicking the natural
molecular organization and morphology of native NP
ECM. The scaffold was developed by combining PCL
electrospinning with gellan gum air brush spraying on a
rotating collector partially immersed in calcium chloride
polymerizing solution [85]. Expectation is high to under-
stand if the remaining non-evaporated chloroform-
methanol solvent residues, used on the electrospinning
side, are below the cytotoxicity threshold for cells loaded
in the gellan gum solution when both reach the collector.
In addition, the polymerization time of gellan gum in ionic
solution is very rapid, a characteristic of interest to be ap-
plied in contemporary fabrication technologies, such as
bioprinting. More recent works propose, as well, the pos-
sibility for gellan gum to be applied in IVD regeneration
[64, 65], corroborating its potential for this application.
Alongside gellan gum is the carboxymethylcellulose,
another polysaccharide suggested for NP tissue engineer-
ing, in this case by Reza and Nicoll [86, 87]. As gellan
gum, carboxymethylcellulose can also be methacrylated,
acquiring the photo-polymerisation ability. However, its
application for NP degeneration treatment has only been
proposed in the methacrylated form [88–90], due to the
reversible nature of conventional ionic cross-linking tech-
niques [86]. Since 2009/10, this research team has exten-
sively characterised methacrylated carboxymethylcellulose
material’s properties, namely: Mechanical, swelling ratio,
and diffusion, with and without seeded cells [86, 88, 90].
Reza et al. [87] analysed the ECM development and func-
tional properties of NP cells within this hydrogel. They
compared two different types of culture medium - the
standard serum-containing medium formulation versus
a serum-free chemically defined medium, both supple-
mented with transforming growth factor-β3. Glycos-
aminoglycan and collagen II content was significantly
greater in serum-free constructs, as well as the Young’s
modulus, and the equilibrium weight-swelling ratio of
the same constructs approached that of the native NP
tissue. The results showed why the use of a chemically
defined medium is so relevant, undoubtedly weighted
by its high cost, therefore, although pertinent, it does
not indicate that it is economically viable. More re-
cently, the differentiation profile of mesenchymal stem
cells into NP-like cells was studied, within this material,
based on the transforming growth factor-β3’s rate of
exposure and cross-linking density. It was reported that
low molecular weight carboxymethylcellulose with low
methacrylation and monomer concentration, provides
more promising results for NP tissue engineering [89].
On another perspective, the continuous supplement of
transforming growth factor-β3 although stimulating
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cells to more interesting results, might not compensate
its significantly higher cost in relation to a transient
supplement. Transient exposure rate seems enough to
reach biochemical and mechanical levels of construct
maturation observed in native NP [88].
To overcome the increased cost of growth factors and
chemically defined serum culture medium for stem cell
differentiation towards NP phenotype, as well as overall
construct maturation, Thorpe et al. [91] cultured human
mesenchymal stem cells in 5% oxygen conditions within a
hydrogel of poly(N-isopropylacrylamide)-(N,N’-dimethyla-
crylamide)-Laponite® – shortly named as pNIPAM-DMAc-
Laponite®. Results shown expression of native NP-like
phenotypic markers and ECM. Therefore, by not using
a chondrogenic inducing medium or supplemented
growth factors the regeneration strategy is simplified
[91] and has a lower cost.
Annulus fibrosus (AF)
An optimal treatment for the AF (Fig. 7), aiming its full
regeneration, depends largely on its state of degener-
ation. A mildly degenerated AF having a localized tissue
damage might be treated with a minimal repair interven-
tion [92–94], which can be sufficient to bring the whole
AF to a complete healthy condition. However, engineering
strategies reported in the literature describe that in case the
AF, as a whole, is compromised a total IVD replacement is
required, i.e. including the NP [95–97]. Considering the
biphasic nature of a young healthy IVD [95], it seems
promising to mimic those material properties on both
phases. Research for a biphasic total IVD replacement can,
naturally, be developed for both tissues at the same time or
strictly focused on the AF analogue. With such a high
attention by the research community on NP regeneration
throughout the last decade, as aforementioned, there are
very promising strategies that could be coupled in the de-
velopment of a biphasic scaffold for total IVD regeneration.
The AF connects both cartilaginous endplates and,
together with them, surrounds the NP. Each one of the
cartilaginous endplates is connected to one of the two
adjacent vertebras [4]. Therefore, if the AF is going to be
replaced it needs to be with a scaffold that maintains a
functional structure while providing the conditions for
peripheral ECM to develop across the border between
the AF and the cartilaginous endplates, before biomate-
rial degradation. The IVD’s metabolism is relatively slow,
probably due to their low vascularity nature [98]. Select-
ing the appropriate material to develop an AF replace-
ment scaffold will probably have to respect that time
frame, to achieve a positive long-term outcome.
Cells for annulus fibrosus (AF) regeneration
Unlike the NP, the cellular aspect of AF regeneration strat-
egies described in the literature is not as complex or, at
least, not explored to the same extent. In summary, an AF
scaffold can be developed mainly via three different possi-
bilities: Acellular [99], AF cells [97], or stem cells [100].
AF cells are classified as fibroblast-like [101], and
fibroblasts are one of the easiest primary cell types, if
not the most, to culture in vitro. In fact, usually they are
unwanted, since sometimes they contaminate the isolated
cell culture due to their higher rate of proliferation, repre-
senting the worst and most common type of autologous
contamination in cell isolation procedures [102]. This pro-
liferative advantage is, in this case, a benefit that can be
explored. Whether through the easiness to isolate and
expand native AF cells, which already have the desired
phenotype, or by following an acellular scaffold strategy
and rely on native taxis of fibroblasts or AF cells (in the
case of minimal intervention) from adjacent tissue(s).
Acellular strategies reduce critical procedure steps, costs
and time significantly when compared with seeding
Fig. 6 Micrograph of methacrylated gellan gum hydrogel with one
million rabbit NP cells encapsulated, after overnight culturing. Scale
bar: 200 μm
Fig. 7 Micro computed tomography image top view of the rabbit
AF, surrounding a dark area, which is the NP. Acquisition parameters:
pixel size – 13.18 μm, source – 89 kV and 112 μA. Scale bar: 250 μm
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scaffold approaches. It has the potential to be, in practical
terms, off-the-shelf.
Total IVD replacement strategies, encompassing a
cellular AF-like scaffold, are required to focus on achiev-
ing a final multi-type cellular population. This includes
NP and AF cells, as well as respective progenitor cells to
maintain their concentrations within the desired regions
long after the patient’s intervention. Perhaps for this rea-
son, stem cells are viewed as an interesting cell source to
seed annular scaffolds, since the same cells can be used
to seed the NP scaffold, while maintaining the potential-
ity to differentiate into the respective aimed phenotypes.
Recent research indicates that the most popular stem
cell types for AF regeneration are mesenchymal stem
cells [94, 103] and AF-derived stem cells [100, 104].
Valadà et al. made a very comprehensive review on stem
cell sources for IVD regeneration, including: Muscle-
derived, olfactory, induced pluripotent, hematopoietic,
synovial, embryonic and Wharton’s jelly [105], however,
it was not distinguished the application of each stem cell
type forAF or NP.
There is, however, who believes it might be interesting
to explore cell injection therapy for AF regeneration. Free-
man et al. claimed, to their knowledge, to be the first to
follow that strategy [106]. They started by inducing IDD
on ovine models, using a method they previously de-
scribed [107], which comprises a postero-lateral annulot-
omy incision on the left side. This was followed by 3 days
of post-operative recovery and 6 months of IDD matur-
ation, confirmed by MRI. A postero-lateral injection of
one million allogeneic bone-derived mesenchymal stem
cells, isolated from the iliac crest, was further adminis-
trated on the opposite side of the lesion. MRI was made
after 3 and 6 months, while animals were sacrificed at the
latter time point for a biochemical and histological ana-
lyses of each IVD. Disc height index results expressed a
continued recovery until the last time-point, when its
index equalizes the positive control group, which did not
suffer annulotomy and received a phosphate buffer saline
injection. It is interesting to add that the negative control,
i.e. untreated degenerated IVDs, kept a constant index be-
tween 6 and 12 months, meaning that all annulotomy
IVDs at 6 months were at the lowest level of disc height
index. This study, however, is limited to the type of IDD
originated by physical damage to the AF. Additionally, it is
not possible to infer if this strategy would reverse IDD de-
rived from cartilaginous endplates calcification [7, 14].
Nonetheless, the results demonstrate the importance of
further exploring a more biological and less material-
oriented approach for AF regeneration [106].
Processing of scaffolds for the annulus fibrosus (AF)
The AF varies greatly along its radius, as a consequence,
perhaps, part of the literature on the subject makes a
distinction between inner and outer AF [82, 108]. The
AF and NP are actually a biocomposite structure with
no clear evident borders. Its biochemistry seems to change
gradually as well as significantly along its radius – from
the centre of the NP to the most peripheral layer of the
outer AF. It is not easy to mimic the complex arrange-
ment of the ECM molecules, as if it was a continuous
medium, to form the macro-structure of the IVD. The
most promising way might be to produce a whole IVD
construct by observing the IVD as a discrete assembly of
few regions. There is at least one different type of ECM
component with a concentration that prevails in each one
of the three structures [5]. In opposition is the biochem-
ical and morphological composition of the outer AF. This
anisotropic tissue [109] is mostly made of collagen I, mak-
ing it an extremely elastic tissue [95]. The inner AF, al-
though having more collagenII than the other two types of
tissue, is like a mixture of the other two in terms of me-
chanics and biology, while having a morphological organ-
isation closer to the outer AF [110].
Several biomaterials have been developed and used as
prime-material for preparing scaffolds to address AF
regeneration. Figure 8 shows a typical AF shape that was
replicated by 3D printing PCL based on a reverse engi-
neered rabbit IVD micro-computed tomography (mi-
cro-CT) acquisition [99]. Other interesting biomaterials
proposed on the literature are described in the form of
a significant number of different composites and formula-
tions, based on the same prime-materials, as: Polylactic-
co-glycolic acid [93], silk fibroin [111], collagen [95, 112],
and PCL [97, 99, 113, 114].
As aforementioned, the IVD is an anatomical structure
highly subjected to complex movements and strains [115].
If a construct without pre-maturation is envisioned for
implantation, the material chosen to replace the AF, in the
short-term, must be able to withstand that biomechanical
responsibility until neo-ECM is able to do it. It should
have a similar Young’s modulus that enables the material
Fig. 8 Photograph of a 3D printed PCL rabbit IVD replica. Scale bar:
5 mm
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to sustain high forces while remaining free from plastic
deformation. In the long-term, it must degrade at the
same rate that cells synthesize the neo-ECM.
ECM synthesis and remodelling depends on the bio-
chemical balance existing inside the cell construct. The
piezoelectric properties (i.e. conversion of mechanical force
into electrical signals, and vice-versa) of collagen molecules,
present within it, possibly play an important role in this
process, dependant on the constant cyclic loads applied to
the IVD [116]. The lines of tension change dynamically
according with this load cycles, resulting in degradation
stimulation of the AF scaffold and synthesis of new ECM,
which probably affects piezoelectric effect inside the struc-
ture. Cells are attracted to where pressure is felt, since the
collagen upon mechanical stimulation releases electrical
stimulus that attract and stimulate cells to produce more
ECM, for the whole tissue to be mechanically balanced.
This effect is similar to what happens in almost every tissue
of the human body. Bone is a good example, since trabecu-
lae and its mineralization are coincident with tension lines
felt by the tissue [117]. Scaffolds with piezoelectric proper-
ties, such as collagen-based scaffolds for the AF, have a
head start advantage. In fact, constructs with no piezoelec-
tric properties, when implanted, probably have a cell taxis
disadvantage in relation to surrounding native tissues. In
summary, the way that the scaffolds degrade, and how its
mechanical properties vary with it, is important for the cell
construct to be successful upon implantation.
The matrix of the AF is mainly made of collagen,
being the principal reason why several research groups
have been proposing it for annular scaffold preparation
[112, 118, 119]. Scaffolds made of collagen I or II have
already shown to stimulate IVD cells to produce big
PG’s and long glycosaminoglycan chains [119, 120]. Choy
et al. developed a strategy to produce biphasic scaffolds
composed of mechanically tuned collagen and glycosami-
noglycan molecules, with collagen-glycosaminoglycan
modifications and photochemical-cross-linked collagen
membrane previously developed in separate by their group
[121, 122]. An interesting layer-by-layer approach was
established to progressively prepare the AF scaffold sur-
rounding the NP replacing collagen-glycosaminoglycan
core, this way mimicking the native AF layered morph-
ology. Each layer is produced via the following cycle – the
core is encapsulated in the modified collagen solution and
further removed for photo-cross-linking, it is then dehy-
drated by rolling it over a filter paper and rehydrated again
to create a phase-border between the next layer, which
starts by repeating the first step [95].
PCL has been proposed for numerous biomedical
applications due to its chemical versatility [123], easy
processability and tuning possibility for matching its
mechanical properties to the desired role [124]. In particu-
lar, PCL has a larger elastic domain than other candidate
materials for AF [125], due to its low melting-point of
approximately 60°C [126]. In a recent work at our group,
a 3D printed scaffold made of PCL was developed using a
custom-tailored geometry of a rabbit AF, acquired by
micro-CT and segmented 3D modelling [99]. The thermo-
plastic properties of this material allow it to be processed
by fused deposition modelling 3D printing, providing all
the possibilities that this technology offers. Cultured AF
cells with leachables extracted from those PCL scaffolds
did not develop a cytotoxic effect on AF cells [99]. A
follow-up work was developed that progresses the proof-
of-concept of a custom-tailored scaffold biofabrication to
a patient-specific type. Oner et al. [127] used PCL to 3D
print a patient-specific AF using MRI data acquired within
a clinical environment. This contrasts with the previous
work that used a micro-CT system, which provides signifi-
cantly more data allowing the development of a 3D model
replica with equally higher fidelity to the original scanned
tissue. However, neither CT nor MRI standard clinical im-
aging systems have this level of resolution. Demonstrating
the increased need for the clinical environment to keep up
with equipment requirements of immerging treatment
strategies. Wismer et al. [113] studied the ability of PCL
material to support AF tissue regeneration and its inter-
action with its native cells. It was demonstrated that AF
cells could proliferate in electrospun oriented PCL
sheets, and that the ECM produced was rich in glycos-
aminoglycans [113]. Other studies have also reported
similar findings regarding the compatibility of PCL with
AF cells [128, 129].
Minimal invasive treatments of AF defects, in its turn,
are an approach that carries less risks than a tissue
engineering total IVD replacement approach. Its certifi-
cation and application in the clinics would be probably
easier and fits well with standard procedures, like discec-
tomy. Facing an IVD herniation, the surgeon can decide
to remove the herniated NP tissue and use a suturing
approach to close the damaged region of the AF [130, 131].
Regenerated strategies are being developed to repair the AF
defect and stimulate its regeneration [92, 93]. Xin et al.
developed small cylindrical scaffold plugs, with a diameter
of 1.8 mm, made of polylactic-co-glycolic acid containing
gelatine particles with a diameter range of 280 to 450 μm.
After leaching, a scaffold is produced with an average pore
size within the same diameter range of the gelatine parti-
cles. The plugs were implanted in rabbit models of AF
degeneration, and a successful repair of the AF defect was
verified with an overall degeneration regression [93].
Polytrimethylene carbonate material is generating inter-
est to fabricate space-fillers for AF defects [92, 94, 132].
Long et al. [92] developed a composite repair strategy that
combines a conical space-filler composed of polytrimethy-
lene carbonate secured in place by fibrin-genipin adhesive
sealant, previously tuned to match the shear properties of
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native AF tissue [130]. To completely ensure the non-
extrusion of the implant, a polyurethane membrane patch
is also applied over the implant surrounding the native
tissue. The implantation was carried using previously
extracted bovine coccygeal region-of-motion IVDs, which
were further submitted to biomechanical assessment.
However, the membrane was not enough to eliminate
the risk of implant extrusion. Interestingly, the results
showed an increased performance for the application of
only fibrin-genipin, which decreased the re-herniation
risk to low levels. It is less clear, however, after surpassing
the risk of re-herniation, if the polytrimethylene carbonate
would not achieve better tissue regeneration results in the
long run.
Combined therapy: cell-seeded scaffolds for annulus fibrosus
(AF) regeneration
The main advantages of acellular strategies are related to
its simplicity of production and regulatory point of views,
storage simplicity, sterilization process and low cost. Ideally,
as soon as the scaffold is implanted the degradation time
should start. As previously mentioned, the biomechanical
balance can only be compensated by the ECM synthesis.
Cellular strategies prevail when this goal is mainly
considered, since cells can start producing matrix as
soon as they are seeded and stably attached. Making
taxis of migrating fibroblasts, from surrounding envir-
onment to the cell construct, synergic instead of fun-
damental. It is not clear, however, what approach
would achieve more interesting results in the long
run, since there are advantages and disadvantages on
both sides, as herein reported. Further in vivo studies
on both approaches are required.
The application of urethane-based polymers for AF is
a very interesting idea, due to its very elastic properties.
Nonetheless, a series studies developed last year by Li et
al. use a polyether-carbonate-urethane-urea to electrospun
AF scaffolds, with the promise of being biodegradable
[100, 103, 104]. The work by Zhu et al., in particular,
encompassed a degradation assay, [100], which was ob-
tained following the synthesis protocol of the polymer,
while demonstrating its non-cytotoxic character [133].
What is interesting, however, is the use of AF-derived
stem cells as the cell source. Liu et al. demonstrated that
aligned electrospun fibres increase the AF cell phenotype
expression in comparison with random orientation [104].
Zhu et al. tuned several types of polyether-carbonate-
urethane-urea for different elastic profiles and its effect on
AF stem cell’s gene expression was evaluated [100]. The
authors reported that collagen I expression increased
alongside the material’s elasticity, while collagen II and
aggrecan had a contrary relation.
A biphasic scaffold composed of lamellar regenerated
silk fibroin surrounding a fibrin-hyaluronic acid NP, seeded
with AF cells and chondrocytes, respectively, was reported
by Park et al. [111] following a biomimetic approach. After
silk fibroin dissolution, a sodium alginate solution was
added and injected into cylindrical shaped silicon moulds.
The assemblies were subjected to freeze-drying and further
crystallized in water for 6 hours to generate β-sheet forma-
tion within the silk fibroin. The alginate was removed from
the scaffold by immersion in water for 24 hours and the
toroidal-shaped silk fibroin scaffolds were achieved by
simple punching. The results showed dense lamellar struc-
tures with spaces between lamellas varying from 10 to
400 μm. Cell seeding was more efficient and homogeneous
throughout the scaffold than in their previous study, where
a porous silk fibroin scaffold instead of lamellar was pro-
duced [134]. The morphological structure of the silk fibroin
toroidal IVDs seemed to guide collagen deposition very effi-
ciently [111]. Maybe, with a culture time longer than two
weeks, the cell constructs could obtain the desired mechan-
ical properties, since silk fibroin is strong but not elastic,
therefore, with further deposition of collagen the cell con-
struct could become elastic. Until now, unfortunately, it
does not seem to exist a follow up of this work, which
would be interesting.
IVD tissue engineering research is already extensive
and several obstacles are being surpassed, though there
is an argument not typically addressed, which is the
structural compatibility, not in terms of morphology but
in terms of optimal fitting within the intervertebral
space. The AF is often mimicked by a toroidal shape
scaffold, with not even an IVD-like geometry. Even if the
IVD-like shape is mimicked, the top and down surfaces
are not prepared according to the endplates’ surfaces,
which have unique topographies in each person, espe-
cially in diseased IVDs. Therefore, creating a high poten-
tial for displacement, once implanted, upon cyclic spine
loading. This was recently addressed, by creating a
fused deposition modelling 3D printed AF scaffold, in
which its computer aided design was a result of 3D
modelling based on a real IVD imaging dataset [99].
Briefly, the micro computed tomographic acquisition
focused on the spinal motion segment. During seg-
mentation, the osteochondral borders between the
IVD and the adjacent vertebras were carefully
followed as the top and down edges of the IVD
model, therefore creating a full replica of the original
IVD and providing the potential for a precise fitting
within the intervertebral space.
An alternative for secure implantation between adja-
cent vertebras is to follow, for example, what is already
done with spinal fusion, by removing the IVD and join-
ing the two flat vertebral surfaces together creating one
continuous double vertebra [135]. Instead of joining
those surfaces, however, it might be also possible to
introduce a tissue-engineered spinal motion segment
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that possess top and down osteochondral layers, leaving
exposed a bone-like surface that can attach to the native
sectioned vertebras. Therefore, in line with the strategy
developed by Choy et al. [95], described in the previous
section, Chik et al., envisioned a scaffold that mimics an
entire spinal motion segment [136]. This composite con-
struct is a full IVD assembly of NP-, AF-, and endplate-
like tissues. It employs a strategy previously described by
the same research team, based on micro encapsulation
of mesenchymal stem cells in collagen I to produce
microspheres, named naive subunits. These are used in
two separate differentiating mediums – chondrogenic
and osteogenic. At the end of the third week, both layers
are assembled together with an additional thin layer of
collagen and mesenchymal stem cells in between [137].
The NP core is also prepared following the same method
they previously described [121], based on collagen and
glycosaminoglycans. The NP core was placed between
two osteochondral units with both chondral layers facing
the NP. These assembly was then processed following
the same strategy described by Choy et al. [95], which al-
lows the layer-by-layer encapsulation and polymerization
of photochemically-cross-linked collagen I. In this work,
however, mesenchymal stem cells were added between
each collagen layer, as well as in the NP core. This study
served as a proof-of-concept for this complex strategy,
naturally with that many steps and details, some tuning
is still required, since the construct is not yet able to
match the maturity of a native spinal motion segment in
several aspects. Considering the amount of collagen,
glycosaminoglycans, and mesenchymal stem cells are
required to produce the whole structure. The costs of
applying such strategy, as a treatment, are probably ex-
tremely high. However, it is our understanding that no
one has ever been able to replicate so faithfully a native
IVD in vitro [136].
Conclusions
Reviewing the literature on tissue engineering strategies
for IVD regeneration it is possible to state that extensive
efforts have been made to regenerate the NP alone, but
increasingly for the simultaneous NP and AF has been
addressed. Two of these strategies have stirred the
research community focused on IVD regeneration: In
vivo and ex vivo approaches that balance risk of adverse
effects with treatment efficiency, with the first being
potentially fatal but more efficient.
In tissue engineering field, the literature seems to be
in consensus about using a polysaccharide as a low-cost
NP substituting material. Additionally, due to the high
avascular nature of this tissue a tight compromise is in
order – the degradable biomaterial must allow cell adhesion
and proliferation, while not hampering for angiogenesis to
occur. Gellan gum seems to fulfil these requirements,
having already demonstrated its non-angiogenic potential,
as well as providing an optimal environment for chondro-
cyte culturing, both in vitro and in vivo. Collagen II, as a
more expensive alternative to polysaccharides, has shown
excellent results in vitro regarding NP native-like ECM pro-
duction, possibly aided by its natural piezoelectric proper-
ties when under mechanical stimulated culture conditions.
It would be interesting, perhaps, to assess the combination
of gellan gum doped with collagen II to accomplish the
positive results of both materials. Nonetheless, if a patient
also requires AF regeneration, the NP substituting hydrogel
needs to be integrated in an AF scaffold. Several approaches
for integrating both tissue regeneration substitutes have
been reported, being integrated from the beginning of con-
struct preparation or only just before application. PCL has
been very popular due to its mechanical properties, having
been processed in several different manners with interest-
ing final results. It has, in fact, also been applied within the
biofabrication field, showing the possibility to produce 3D
printed custom-tailored AF scaffolds based on the host
intervertebral geometry. This way further expanding pro-
cessability into a wider range of scaffold shapes and details,
with low-cost and in a short time. Patient-specific therapies
are becoming popular and allow the development of scaf-
folds or constructs that fit the patient’s needs in a precise
manner. This increases the potential for construct integra-
tion into the surrounding tissues, and lowers the risk of
complications, such as scaffold displacement or mechanical
destabilization.
Although the recent reports serve the great purpose of
providing tools to regenerate a greater tissue volume of
the IVD, few strategies have been developed to regener-
ate the cartilaginous endplates. The healthiness of these
plates is, in fact, one of the keys for a healthy cellular
environment within the whole IVD. Regenerating the
other two tissues, alone or together, when the end-
plates are calcified is, therefore, a desperately frustrat-
ing task, ultimately leading towards failure in the
long-run. The strong bonds between the three tissues
that compose the IVD, on all levels, imply that the
tissue engineering path of less resistance is a strategy
that encompasses all tissues together, when consider-
ing late-stage IDD cases. Having into account what
has been developed for NP and AF regeneration leads
to the conclusion that once a successful cartilaginous
endplate regeneration strategy has been developed the
remaining strategies will possibly achieve significantly
better results when applied together. However, full IDD is
not the only clinical condition of this disease. Research on
minimally invasive surgical approaches and repair/regener-
ation strategies that rely on the use of patient-specific im-
plants, for the AF and NP, play an important role in finding
appropriate clinical solutions for less severe, but still pain-
ful, conditions of IDD.
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